Autotaxin inhibitor treatment for IPF - Milan 2023

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses Milan 2023 Autotaxin inhibitor treatment for IPF

Highlights from the Journal of the American Medical Association

Chair(s): Nicolas Roche, Kristin Walter

Session type: Journal session

Autotaxin inhibitor treatment for IPF

Marlies S. Wijsenbeek

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

Global burden of long COVID

Merel Hellemons

Replay

Slides

Morphine for breathlessness in COPD

Magnus Ekstrom

Replay

Slides

Autotaxin inhibitor treatment for IPF

Marlies S. Wijsenbeek

Replay

Slides

Discussion and Q&A

Replay

Session aims

to provide an update on the global burden of long COVID; to provide information about the use of morphine to treat breathlessness in patients with chronic obstructive pulmonary disease (COPD); to provide information about the effect of autotaxin inhibitor treatment on lung function in patients with idiopathic pulmonary fibrosis (IPF).

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}